You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
CVS Health announces quarterly dividend of USD0.665 per share
19 March 2026 -

US healthcare company CVS Health (NYSE:CVS) announced on Wednesday a quarterly dividend of USD0.665 per share on its common stock.

This amount is unchanged from the previous quarterly dividend.

It will be paid on 4 March 2026 to shareholders of record at 23 April 2026.

Login
Username:

Password:


Related Headlines

West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m

Citius Pharmaceuticals reports full-year financial results

Sanofi receives FDA complete response letter for tolebrutinib in progressive MS

Abbott announces quarterly common dividend increase

Amgen announces Q1 2026 dividend

Eli Lilly announces Q1 2026 dividend

Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation

Amgen announces Q4 2025 dividend

Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses

Perrigo to pay quarterly dividend of USD0.290 per share

Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities

Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma

Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio

IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera

AstraZeneca strikes landmark drug pricing deal with US Government

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026